Clinical trial

Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00083161

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-06-01

PhasePHASE2

Study timeline

Study start (unknown)2003-06-01Date precision: month

Registry last updated2012-09-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

cisplatinDRUG · verified · RxNorm: cisplatin

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

etoposideDRUG · verified · RxNorm: etoposide

Sponsors & collaborators

Gundersen Lutheran Health Systemlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00083161 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.